What AI says about MagnaPulse
MagnaPulse produces pulsed electromagnetic field (PEMF) therapy systems designed to address autoimmune conditions such as ankylosing spondylitis. The company’s approach is based on a model suggesting PEMF increases cell membrane potential to reduce Tumor Necrosis Factor-mediated immune responses.
AI named MagnaPulse in December 2025.